Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Molecular Immunology|July 15, 2011
PD-L2 is expressed on activated human T cells and regulates their functionNassima Messal, Nacer-Eddine Serriari, Sonia Pastor, et al.STAR Protocols|February 28, 2023
Production of CRISPRi-engineered primary human mammary epithelial cells with baboon envelope pseudotyped lentiviral vectorsSonia Pastor, Julien Wicinski, Emmanuelle Charafe-Jauffret, et al.The Journal of Rheumatology|February 3, 2020
Persistence of Crystals in Stored Synovial Fluid SamplesSonia Pastor, José-Antonio Bernal, Rocío Caño, et al.International Immunology|July 1, 2010
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1Marguerite Ghiotto, Laurent Gauthier, Nacer Serriari, et al.Revista Latino-Americana De Enfermagem|September 20, 2012
Understanding the suffering of a patient with an illness: signs, context and strategiesCésar Hueso Montoro, José Siles González, Manuel Amezcua, et al.Scientific Reports|December 21, 2023
SLEEP quality in patients with psoriatic arthritis and its relationship with disease activity and comorbidities: a cross-sectional studyEsther Toledano, Cristina Hidalgo, Luis Gómez-Lechón, et al.International Immunology|October 23, 2012
PD-1 is a novel regulator of human B-cell activationMarie-Laure Thibult, Emilie Mamessier, Julie Gertner-Dardenne, et al.Oncogene|December 3, 2003
Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinaseAudrey Gérard, Cédric Favre, Fabien Garçon, et al.The Journal of Clinical Investigation|December 30, 2009
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccinationLaurent Derré, Jean-Paul Rivals, Camilla Jandus, et al.Journal of Molecular Medicine (Berlin, Germany)|August 21, 2012
CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cellsMarie-Laure Thibult, Jean-Paul Rivals, Emilie Mamessier, et al.Pageof 3